Diagnosis and mechanism
Primary or secondary regurgitation and rheumatic or calcific stenosis are different problems. The documented diagnosis and cause shape which questions and procedures belong in the discussion.

Your Incision Should Be Your Decision™
Mitral valve second opinion
A cardiac surgeon and cardiologist independently review the records and imaging required for your case, then co-sign one report explaining the diagnosis, timing, and only the paths relevant to you.
What happens next: A member of our team will call within 2 business hours. During business hours, a same-day conversation with a cardiac surgeon or cardiologist may be arranged only when clinically appropriate and a physician is available.
No referral or travel required for the written review. With your authorization, the records team can help obtain what is needed. The written review includes two independent physician reviews and one co-signed written report; it does not include a live physician consultation. The Consult plan includes everything in the written review plus one live consultation with one reviewing physician. Pricing is shared during your complimentary discovery call.


The question is not simply “repair, replacement, or a catheter procedure?” It is “which paths fit this diagnosis, this anatomy, and the whole heart?”
Message Us about my decisionOne clear way to begin
Tell us whether repair, replacement, TEER, balloon treatment, or continued follow-up was discussed—and which part of the recommendation still feels unclear.
No referral · no travel · no obligation to purchaseA sentence is enough. Include what was recommended, what is scheduled, and what still feels unresolved.
A member of the team helps determine which records and images matter and can help with retrieval after authorization.
The written review always includes a cardiac surgeon, a cardiologist, and one co-signed report. Live physician time is optional.
First, name the valve problem
Mitral regurgitation and mitral stenosis can share symptoms, but they do not share one treatment pathway. Cause, anatomy, severity, symptoms, heart response, and available procedures must be reviewed separately. Continue following your treating team’s instructions while seeking clarification.
Primary or secondary regurgitation and rheumatic or calcific stenosis are different problems. The documented diagnosis and cause shape which questions and procedures belong in the discussion.
Symptoms, serial echocardiograms, pulmonary pressures, rhythm, exercise tolerance, and changes in left-ventricular size or function help explain why intervention is—or is not—being discussed now.
Leaflet motion, prolapse or restriction, annular dimensions, calcium, coaptation, commissures, valve area, and gradient can change which surgical or transcatheter approaches are technically reasonable.
Coronary disease, atrial fibrillation, tricuspid or aortic valve disease, and ventricular dysfunction may favor a combined operation, a staged plan, or a different sequence of care.
For mitral regurgitation
The right comparison starts with the diagnosis. Primary MR, secondary MR, and mitral stenosis require different reasoning. The review identifies which paths are clinically relevant to discuss—and why.
For primary degenerative MR, surgical repair is generally preferred over replacement when a successful and durable repair is expected. Repairability depends on the lesion, tissue quality, calcium, prior treatment, and experience relevant to that anatomy. A record review cannot promise that repair will be possible or durable.
Replacement may be considered when a durable repair is unlikely or inappropriate because of rheumatic disease, heavy calcification, tissue destruction, prior procedures, or other anatomy. When replacement is relevant, prosthesis choice, anticoagulation, durability, lifestyle, and future procedures belong in the same discussion.
TEER is not a universal alternative to surgery. It may be considered for selected patients with severe symptomatic primary MR, suitable anatomy, and high surgical risk; and for selected patients with severe symptomatic secondary MR despite optimized guideline-directed heart-failure therapy and cardiac resynchronization when indicated. Candidacy also depends on ventricular, pulmonary-pressure, and anatomic criteria assessed by the treating multidisciplinary valve team.
Mitral stenosis follows a different fork: repair and TEER framing for regurgitation should not be carried over. The treating valve team may instead discuss surveillance, medical or rhythm care, balloon commissurotomy, selected transcatheter approaches, or surgery depending on cause and anatomy. Another reasonable step may be to complete the workup or revisit timing. WHITEGLOVEMD does not diagnose, prescribe treatment, or replace the clinicians directing your care.
The anatomy and durability view
A useful review looks beyond the immediate recovery to residual regurgitation or stenosis, recurrent disease, reintervention, prosthesis implications, and whether the rest of the heart should be treated at the same time.

Posterior, anterior, bileaflet, restricted, calcified, rheumatic, and previously treated valves do not carry the same technical questions. A review should name what the available imaging does—and does not—show.
A procedure may be technically possible without being the most durable path. Residual regurgitation, stenosis, recurrent disease, reintervention, and the consequences of a failed strategy deserve attention.
In primary MR the valve itself is diseased. In secondary MR, ventricular or atrial remodeling can prevent otherwise structurally normal leaflets from meeting normally. The role of medical, device, catheter, and surgical treatment can therefore differ.
If repair is not considered durable, mechanical and tissue prostheses bring different trade-offs involving anticoagulation, durability, bleeding, thrombosis, lifestyle, and future procedures.
Bypass, atrial fibrillation surgery, tricuspid repair, or another valve procedure may sometimes be addressed during the same operation. That can alter a comparison with a single-lesion catheter procedure.
Recovery, anticoagulation, future procedures, caregiving, work, travel, and tolerance for uncertainty are legitimate inputs to shared decision-making.
Independent dual review
Both plans include both independent reviews and both physician signatures. The physicians confer before the report is finalized.
Repairability · replacement strategy · operative access · combined procedures · lesion-specific program fit
Mechanism · severity · ventricular response · TEER anatomy · medical and rhythm context · surveillance
WHITEGLOVE Insights™
The report is written for patients and families, but grounded in the complete source record, current evidence, and two physician reviews.
See a sample reportThe documented diagnosis and cause, symptoms, serial testing, heart response, treating team’s plan, and the findings driving the discussion—clearly tied to the source record.
The benefits, burdens, technical considerations, and unanswered questions for repair, replacement, TEER, balloon commissurotomy, monitoring, or other paths only when clinically relevant.
Leaflet involvement, motion, coaptation, commissural, annular and subvalvular findings, calcium, valve area, gradients, and the limits of the available imaging.
The current STS ACSD operative-risk estimate when applicable, with verified inputs, calculation date, missing data, and model limitations made visible. Other models are discussed only when documented in the source record.
Patient-facing explanations connect the relevant echo, TEE, catheterization, and imaging findings to the decision in front of you.
A practical check for unresolved imaging, measurements, testing, or clinical context to discuss with the treating team.
Lesion-specific repair experience, valve-program capability, geography, practical considerations, and reliable public outcomes when requested and available.
A concise set of questions and next steps to bring back to the physicians who know you and will provide your care.
Ready for an independent read?
The written-review option includes both independent physician reviews and one co-signed written report. Live consultation is not included at this level.
What may still be missing
A missing study does not automatically mean care was inadequate. It means the limits of the available review should be visible—and turned into useful questions for the treating team.
MR mechanism and severity, chamber size, ventricular function, pulmonary pressure, other valves, and serial change—not only one number from one study.
When clinically relevant, transesophageal echocardiography can clarify leaflet segments, coaptation, calcium, repairability, and TEER anatomy. Its absence is a question—not automatically an error.
Whether coronary disease is present and whether bypass or another coronary strategy changes the choice or sequence of treatment.
Atrial fibrillation, tricuspid disease, aortic valve disease, pulmonary pressure, and right-ventricular status may change a combined plan.
The clinical and laboratory variables needed for a defensible estimate, plus the limits of every model.
Exercise tolerance, congestion, medication strategy where relevant, kidney and pulmonary status, frailty, and what has changed over time.
Evidence, with its limits visible
Risk estimates describe modeled outcomes for patients with similar inputs. They do not predict an individual result and do not replace clinical judgment.
How it works
The report is delivered within 24 hours only after all required records and imaging are received and confirmed complete. Time spent gathering missing records is outside the 24-hour window.
Tell us what you were told, what is already scheduled, and what still feels unresolved. No referral or records are needed to begin.
Upload what you have or authorize the records team to help gather the echocardiography and TEE when available, catheterization, imaging, notes, labs, and proposed plan required for the review.
A cardiac surgeon and cardiologist examine the same record set received and confirmed complete for this review from different clinical perspectives, then confer.
The report is delivered within 24 hours only after all required records and imaging are received and confirmed complete. Time spent gathering missing records is outside the 24-hour window.
Mitral valve second opinion FAQ
A second opinion can be useful when repair, replacement, TEER, or continued monitoring is being discussed and you want to understand the mechanism of regurgitation, the timing, repairability, alternative approaches, individual risk, or whether another cardiac problem changes the plan. It should not delay urgent or time-sensitive care directed by your treating team.
Sometimes, but not every valve is durably repairable. The answer depends on the actual mechanism, leaflet and annular anatomy, calcification, tissue quality, prior procedures, and experience relevant to that lesion. The review organizes what the available imaging suggests, what remains uncertain, and why repair or replacement is being proposed without promising a repair result.
Primary mitral regurgitation begins with disease of the valve apparatus, such as prolapse or a flail leaflet. Secondary regurgitation occurs because changes in the ventricle or atrium prevent the leaflets from meeting normally. The distinction matters because the roles of repair, replacement, TEER, medical therapy, rhythm treatment, and monitoring can differ.
Yes. Mitral regurgitation is a leaking valve; mitral stenosis is a narrowed valve. Mitral stenosis raises different questions about cause, valve area and gradients, symptoms, rhythm and clot-prevention context, anatomy, and whether monitoring, balloon commissurotomy, or surgery is relevant. Repair and TEER language on this page applies to regurgitation only when supported by the record.
TEER is not a universal alternative to surgery. It may be considered for selected patients with severe symptomatic primary MR, suitable anatomy, and high surgical risk; and for selected patients with severe symptomatic secondary MR despite optimized guideline-directed heart-failure therapy and cardiac resynchronization when indicated. Ventricular status, pulmonary pressure, anatomy, and assessment by the treating multidisciplinary valve team also matter. A catheter procedure is not automatically better or less appropriate than surgery.
Yes, when replacement is a relevant option. The report can organize trade-offs involving durability, lifelong anticoagulation, bleeding and clotting considerations, lifestyle, pregnancy considerations when relevant, and possible future procedures. It does not prescribe a prosthesis; the final choice belongs with you and your treating physicians.
The exact record depends on the decision. It commonly includes transthoracic echocardiogram images and reports, TEE images and report when performed or clinically relevant, catheterization or coronary assessment, clinical notes, laboratory results, medication history, rhythm information, and the proposed treatment plan. With your authorization, the records team can help identify, request, and organize what is needed.
A cardiac surgeon and cardiologist independently review the same record set received and confirmed complete for the review, then confer and co-sign one WHITEGLOVE Insights™ report. Both perspectives are included at every service level.
The report is delivered within 24 hours only after all required records and imaging are received and confirmed complete. Time spent gathering missing records is outside the 24-hour window.
WHITEGLOVE Insights™ includes two independent physician reviews and one co-signed written report; it does not include a live physician consultation. WHITEGLOVE Consult includes everything in the written-review plan plus one live consultation with one reviewing physician. Pricing is shared during your complimentary discovery call. WHITEGLOVEMD is a direct-pay service and does not submit insurance claims.
No. WHITEGLOVEMD provides independent educational decision support and medical-record review. It does not diagnose, prescribe, perform procedures, provide emergency care, or replace the physicians responsible for your treatment.
Do not delay urgent or time-sensitive treatment while waiting for WHITEGLOVEMD. If you may be experiencing a medical emergency, call 911 immediately.
A clearer next conversation starts here
Message us about what you were told, what is scheduled, and what still feels unresolved. We’ll explain the next step and help identify the records and imaging needed for review.
The written review includes two independent physician reviews and one co-signed written report. The Consult plan includes everything in the written review plus one live consultation with one reviewing physician. Pricing is shared during your complimentary discovery call.
A member of our team will call within 2 business hours. During business hours, a same-day conversation with a cardiac surgeon or cardiologist may be arranged only when clinically appropriate and a physician is available.